Purchase Order 75N92023P00375
Award Date 9/28/23
Potential Completion Date 9/27/28
Potential Value $65K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $29,795.40 on January 23, 2019, for a maintenance agreement with an ultimate completion date of January 31, 2020. Work is performed at Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied. The maintenance agreement supports BD flow cytometry instrumentation operated by the Institute, consistent with BD Biosciences' established supplier...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Becton, Dickinson And Company (BD) on January 10, 2020 for the maintenance of a BD Fortessa flow cytometer analyzer. The contract has a potential value of $223,064.40 and a completion date of January 12, 2025. The place of performance is Bethesda, Maryland. BD is a global medical technology company that provides a...
- The National Heart Lung and Blood Institute (NHLBI) awarded a purchase order to Becton, Dickinson and Company's BD Biosciences division for continued operation and maintenance services of a BD Fortessa flow cytometer (Serial No. H647794L5026) at its Pulmonary Critical Care Branch facility in Bethesda, Maryland. The contract, valued at $118,943.64 under firm fixed pricing, supports the instrument's state-of-the-art capabilities for assessing fluorescent probes in biomedical research applications....
- This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...
- The National Heart Lung and Blood Institute (NHLBI) awarded a $122,622.24 firm fixed-price purchase order to Becton, Dickinson and Company's BD Biosciences division for a maintenance agreement covering a BD LSRFortessa flow cytometry system equipped with four lasers (blue, red, violet, and ultraviolet) and one computer workstation. The contract was awarded on May 26, 2025, with an ultimate completion date of May 25, 2029, and will be performed at the NHLBI's location in Bethesda, Maryland. No...
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for an LSRFortessa multi-year maintenance agreement with a ceiling value of $283,987.80, awarded November 17, 2014, with ultimate completion November 20, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. This is a maintenance agreement supporting flow cytometry instrumentation at a federal research facility, typical of BD...
- This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...
- This is a firm fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The $21,900.48 contract is for a service contract to maintain the NHLBI's FACS Fortessa X-20 SORP flow cytometry instrument. This contract does not have a set-aside designation, indicating it was competed on a full and open basis. BD, a...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $22,107.60 firm fixed-price purchase order to Becton, Dickinson and Company's BD Biosciences division for instrument service contract support to the Flow Cytometry Core facility. The single award contract, effective February 1, 2026 through January 31, 2027, provides maintenance and technical support services essential to sustaining the state-of-the-art flow cytometry facility that supports biomedical research conducted by NHLBI...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) on January 13, 2019, for BD Fortessa flow cytometer maintenance services with a ceiling value of $37,409.40 and an ultimate completion date of January 12, 2020. Work is performed in Bethesda, Maryland. The contract carries firm fixed-price terms and no small business set-aside.</p>